Status:
COMPLETED
Improving Assessment (and Ultimately Outcomes) of Permanent Prostate Implant Therapy
Lead Sponsor:
AHS Cancer Control Alberta
Collaborating Sponsors:
Cross Cancer Institute
Conditions:
Prostate Cancer
Eligibility:
MALE
Phase:
NA
Brief Summary
Permanent prostate implants are a type of radiation therapy in which a high dose of radiation is delivered to cancerous tissue by many small radioactive "seeds". Studies of early-stage prostate cancer...
Detailed Description
This study addresses three major sources of post-implant dosimetry inaccuracy for permanent prostate implants: post-operative edema, prostate contour delineation, and dose calculation method. It is hy...
Eligibility Criteria
Inclusion
- Candidate for permanent prostate implant
Exclusion
- Not ambulatory
Key Trial Info
Start Date :
April 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2013
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00127816
Start Date
April 1 2005
End Date
April 1 2013
Last Update
March 16 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cross Cancer Institute
Edmonton, Alberta, Canada, T6G 1Z2